Epstein Secrets

ons Repatriating Dividends Under IRC Section 965, Company Repatriated Amount ($bn) Selected Items, by Selected Major and Minor Industry of the Parent Pfizer 355 Corporation, Tax Years 2004-2006 Merck 15.9 Industry % of Repatriated Cash Dividends Hewlett Packard 145 Pharmaceutical and medicine manufacturin

ring 8% Schering-Plough 94 Food manufacturing ; 6% j Other chemical manufacturing 5% Bristol Myers 9.0 Information {including software publishers} 4% Eli Lilly 8.0 Finance, insurance, real estate, rental and leasing 4% DuPont 17 Transportation equipment manufacturing 3% Pepsi Co, Inc. 14 Management of compan

t Animal Health to Lilly for $5.4B (NOVN VX +2.3%, GSK LN +5.3%, LLY no volume) • Astrazeneca ADR's closed +8.8% yesterday on Sunday Times story of Pfizer talks (trading +6.9%) • Philips misses estimates, adjusted EBITA 12% light on HC + lighting, weaker EM & FX (trading -7.0%) • Accor O1 sales miss

is agrees to buy GSK's oncology unit for as much as $16B, Novartis to sell vaccines unit to Glaxo for $7.1B, Novartis to sell Animal Health unit to Eli Lilly for — $5.4B. And Philips is currently trading -7.0% after missing estimates due to HC + lighting as well as weaker EM and FX. Earnings kicking into

Biden said Tuesday that "he hopes to have enough vaccine for 300 million Americans by the end of the summer, ordering another 100 million doses from Pfizer and 100 million doses additional from Moderna. It comes as the global pandemic now reaches a staggering new toll: more than 100 million cases world

to fight COVID-19, suggesting they can help keep patients out of the hospital and possibly prevent illness in some uninfected people." On Tuesday, Eli Lilly said that a "two-antibody combo reduced the risk of hospitalizations or death by 70% in newly diagnosed, non-hospitalized COVID-19 patients at high